前列腺素E2通过依赖于乳毛的ROCK2激活来抑制脂肪生成
Mark D Lee1, Keren I Hilgendorf1
1Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Journal of cell science
|September 16, 2025
概括
前列腺素E2 (PGE2),一种炎症分子,通过初级眼发出信号,阻止新脂肪细胞的产生 (脂肪生成). 这一发现揭示了炎症如何损害脂肪组织功能和代谢健康.
科学领域:
- 细胞生物学 细胞生物学
- 代谢性疾病研究研究
- 脂肪组织生物学 脂肪组织生物学
背景情况:
- 功能性脂肪组织对于代谢平衡至关重要.
- 功能失调的脂肪组织,以纤维化,缺氧和炎症为标志,与肥胖和2型糖尿病有关.
- 脂肪生成,即新脂肪细胞的产生,对于在营养过剩期间保持脂肪组织功能至关重要.
研究的目的:
- 为了确定脂肪生成的生理调节者.
- 研究前列腺素E2 (PGE2) 在脂肪生成中的作用.
- 阐明 PGE2 影响脂肪细胞干细胞分化的信号通路.
主要方法:
- 研究了脂肪细胞干细胞中的前列腺素E2 (PGE2) 信号传导.
- 使用免疫光学检测EP4受体定位在初级眼上.
- 分析了EP4激活对cAMP水平和ROCK2活性的影响.
- 评估了信号通路对actin应激纤维形成和脂肪生成的影响.
主要成果:
- 发现了一个毛局部化的信号通路,其中PGE2抑制了脂肪生成.
- 证明PGE2通过E型前列腺素受体4 (EP4) 在脂肪细胞干细胞的初级乳头上发出信号.
- 表明状EP4激活会导致ROCK2.2的cAMP独立激活.
- 确定激活的ROCK2保留了actin应力纤维,抑制了脂肪生成.
结论:
- 主要毛细分隔信号通路,以调节脂肪生成.
- 通过状EP4和ROCK2作用的PGE2抑制了脂肪细胞干细胞的分化.
- 这种机制提供了关于慢性炎症如何导致脂肪组织功能障碍和代谢疾病进展的见解.
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
Cell Specific Gene Expression
16.3K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.3K
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
Glucagon-like Receptor Agonists
850
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
850
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K


